| Reversible cholinesterase inhibitors as pretreatment for exposure toorganophosphates. A review. | J Appl Toxicol | 2018 Jul 19 | 30027640 |
| Interaction Between 2 Nutraceutical Treatments and Host Immune Status in thePediatric Critical Illness Stress-Induced Immune Suppression ComparativeEffectiveness Trial. | JPEN J Parenter Enteral Nutr | 2017 Nov | 27660289 |
| Using Chemoinformatics, Bioinformatics, and Bioassay to Predict and Explain theAntibacterial Activity of Nonantibiotic Food and Drug Administration Drugs. | Assay Drug Dev Technol | 2017 Apr | 28346800 |
| Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog. | BMC Vet Res | 2015 Jun 19 | 26087767 |
| Single-step multiresidue determination of ten multiclass veterinary drugs inpork, milk, and eggs using liquid chromatography with tandem mass spectrometry. | J Sep Sci | 2015 Aug | 26033853 |
| Understanding variability in posaconazole exposure using an integrated populationpharmacokinetic analysis. | Antimicrob Agents Chemother | 2014 Nov | 25199779 |
| Acetylcholinesterase inhibitors as pretreatment before acute exposure toorganophosphates: assessment using methyl-paraoxon. | CNS Neurol Disord Drug Targets | 2012 Dec | 23244429 |
| Delayed gastric emptying: whom to test, how to test, and what to do. | Curr Treat Options Gastroenterol | 2006 Jul | 16836948 |
| Influence of metoclopramide on gastroesophageal reflux in anesthetized dogs. | Am J Vet Res | 2006 Jan | 16426208 |
| [Residue analysis of metoclopramide in bovine and swine tissues by HPLC andadministration experiment]. | Shokuhin Eiseigaku Zasshi | 2006 Dec | 17228790 |